ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

ORI Finds Misconduct By CIT Professor

August 4, 1995

51% Control Rate Achieved In Phase II Trial of Elderly Patients

March 29, 2013

Funding Opportunities

September 27, 2002

NIH News: Board of Governors Appointed to Oversee Clinical Center

October 24, 1996

In Brief: Jane Henney Sworn In As FDA Commissioner; Six Centers Retain Comprehensive Status

December 18, 1998

In Brief: Baltimore Names ACS Research Professor; Currie, Sachdeva Lead Education Association

December 9, 1994